Ru Li

Ru Li

Directeur/Membre du Conseil chez CHONGQING TAIJI INDUSTRY(GROUP) CO.,LTD
47 ans
Health Technology
Consumer Services

Profil

Ru Li currently works at Shanghai Shyndec Pharmaceutical Co., Ltd., as Director from 2022, China National Pharmaceutical Group Co., Ltd., as Deputy Director & Director-Risk & Operation from 2012, Sinopharm Common Wealth Co. Ltd., as Director, Chongqing Taiji Industry (Group) Co., Ltd., as Member-Supervisory Board from 2021, and China National of Traditional & Herbal Medicine Co., Ltd., as Member-Supervisory Board.
Ms. Li also formerly worked at China Traditional Chinese Medicine Holdings Co. Ltd., as Non-Executive Director from 2019 to 2025, Takeda AS, as Market Manager from 2010 to 2012, and China National Medicines Co., Ltd., as Manager-Product, Regional & Divisional Sales from 2001 to 2010.
Ms. Li received her undergraduate degree in 2001 from Shenyang Pharmaceutical University.

Postes actifs de Ru Li

SociétésPosteDébut
CHONGQING TAIJI INDUSTRY(GROUP) CO.,LTD Directeur/Membre du Conseil 19/05/2021
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Directeur/Membre du Conseil 28/11/2022
Directeur/Membre du Conseil -
Corporate Officer/Principal 01/01/2012

Anciens postes connus de Ru Li

SociétésPosteFin
CHINA TRADITIONAL CHINESE MEDICINE HOLDINGS CO. LIMITED Directeur/Membre du Conseil 15/01/2025
Sales & Marketing 01/01/2012
CHINA NATIONAL MEDICINES CORPORATION LTD. Corporate Officer/Principal 01/01/2010
Voir l'expérience en détail de Ru Li

Formation de Ru Li

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

42

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées8

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services